Science Explorer Interactive view Map
Funder · London · United Kingdom

Blood Cancer UK

In research, Blood Cancer UK stands highest in Medicine (#4,130 of 17,978 worldwide), Health Sciences (#5,617 of 20,462 worldwide) and Life Sciences (#5,513 of 14,347 worldwide), over all time.

World rank, all time
#10,416
of 42,892
Rank in United Kingdom
#574
of 2,253
Research works
562
▲ 48% vs 2013–17
Citations
26k
46.8 per fractional work
Top-10% rate
16.7%
record average 16.5%
Open access
33%
world 28%

What is Blood Cancer UK known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #4,130 of 17,978 28.5%351
Health SciencesDomain #5,617 of 20,462 28.4%359
Life SciencesDomain #5,513 of 14,347 23.9%173

Each strip is that field’s whole ranked pool, with the notch where Blood Cancer UK sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.10× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.93× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 1.62× its world share, 0 worksImmunology and Micro…Neuroscience: 0.54× its world share, 0 worksNeuroscienceChemistry: 0.93× its world share, 0 worksChemistryComputer Science: 1.10× its world share, 2 worksComputer ScienceEarth and Planetary Sciences: 0.74× its world share, 0 worksEarth and Planetary …Engineering: 0.13× its world share, 0 worksEngineeringEnvironmental Science: 0.70× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.33× its world share, 0 worksMaterials ScienceMathematics: 0.08× its world share, 0 worksMathematicsHealth Professions: 0.16× its world share, 0 worksHealth ProfessionsMedicine: 2.95× its world share, 16 worksMedicineEconomics, Econometrics and Finance: 0.15× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.06× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.9×. Every wedge is a field page.

Who are the top researchers at Blood Cancer UK?

Ranked on the composite score, Leanne M. Wiedemann and JM Goldman lead among researchers whose main affiliation is Blood Cancer UK.

  1. 1 Leanne M. Wiedemann United Kingdom · #256,970 worldwide 120 citations · 18 works
  2. 2 JM Goldman United Kingdom · #308,075 worldwide 133 citations · 22 works
All ranked researchers at Blood Cancer UK

Which keywords describe research at Blood Cancer UK?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Prognostic Factors, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML, Mutation, BCR-ABL, Imatinib and Rituximab.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 22 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Prognostic Factors6▲ 47×5 topics
  2. Hematopoietic Stem Cells4▲ 175×3 topics
  3. AML4▲ 252×1 topic
  4. Acute Myeloid Leukemia4▲ 252×1 topic
  5. Mutation3▲ 54×3 topics
  6. BCR-ABL3▲ 352×1 topic
  7. Imatinib3▲ 352×1 topic
  8. Rituximab2▲ 48×2 topics
  9. Chronic Lymphocytic Leukemia2▲ 137×1 topic
  10. Genomic Aberrations2▲ 137×1 topic
  11. Therapeutic Targets2▲ 42×2 topics
  12. Deep Learning2▲ 1.62×7 topics
  13. Cancer1▲ 3.5×15 topics
  14. Classification1▲ 9.5×3 topics
  15. Epidemiology1◆ 1.04×9 topics
  16. Immune Response1▲ 6.6×8 topics
  17. Mortality1▲ 6.6×3 topics
  18. Public Health1▲ 2.6×2 topics
  19. Transcriptional Regulation1▲ 24×4 topics
  20. Climate Change1▲ 1.36×2 topics
  21. Heat Waves1▲ 55×1 topic
  22. Human Health1▲ 22×1 topic

Which research topics does Blood Cancer UK publish most on?

By volume in 2022–2025: Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research and Climate Change and Health Impacts.

  1. 1 Acute Myeloid Leukemia Research Hematology 4 works
  2. 2 Chronic Myeloid Leukemia Treatments Hematology 3 works
  3. 3 Chronic Lymphocytic Leukemia Research Genetics 2 works
  4. 4 Climate Change and Health Impacts Health, Toxicology and Mutagenesis 1 works
  5. 5 Eosinophilic Disorders and Syndromes Rheumatology 1 works
  6. 6 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 1 works
  7. 7 Protein Degradation and Inhibitors Molecular Biology 1 works
  8. 8 Hematopoietic Stem Cell Transplantation Hematology 1 works
  9. 9 Hemoglobinopathies and Related Disorders Genetics 1 works
  10. 10 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.8%not open67.2%

World: 28% of research is openly available.

with international co-authors21.6%domestic only78.4%

World: 19% is written across borders.

How has Blood Cancer UK's research output changed?

Output in 2018–2022 was 48% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in London

All research institutions in London

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.